Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Hematology-Oncology

NEW YORK (Reuters Health) – A European study indicates that patients with T-cell prolymphocytic leukemia may respond well to induction chemotherapy using fludarabine, mitoxantrone and cyclophosphamide, followed by consolidation with...

Reuters Health • The Doctor's Channel Daily Newscast

Graft-Versus-Tumor Effect of Hematopoietic Cell Transplantation May be Curative

NEW YORK (Reuters Health) – Even without conventional conditioning and cytoxic chemotherapy, an allogeneic hematopoietic cell transplant (HCT) can have a substantial benefit in patients with advanced hematologic malignancies. That finding comes from a...
A new article in The New York Times reports a new treatment that can genetically alter a patient’s own immune cells and result in remissions for adults with an acute leukemia that is usually lethal. “The treatment is experimental, has been...